---
title: "Fosamprenavir - Human immunodeficiency virus infection"
sidebar: mydoc_sidebar
permalink: db01319-mesh-d015658-1.html
toc: false 
---


Path ID: `DB01319_MESH_D015658_1`
{% include image.html url="images/db01319-mesh-d015658-1.png" file="db01319-mesh-d015658-1.png" alt="db01319-mesh-d015658-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C426859 | fosamprenavir | Drug |
| CHEBI:40050 | amprenavir | ChemicalSubstance |
| UniProt:Q72874 | HIV-1 protease | Protein |
| UniProt:P04591 | Gag polyprotein | Protein |
| GO:0019068 | virion assembly | BiologicalProcess |
| NCBITaxon:11676 | Human immunodeficiency virus 1 | OrganismTaxon |
| MESH:D015658 | Human immunodeficiency virus infection | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Fosamprenavir | INCREASES ABUNDANCE OF | Amprenavir |
| Amprenavir | DECREASES ACTIVITY OF | Hiv-1 Protease |
| Hiv-1 Protease | INCREASES ACTIVITY OF | Gag Polyprotein |
| Gag Polyprotein | PARTICIPATES IN | Virion Assembly |
| Virion Assembly | IN TAXON | Human Immunodeficiency Virus 1 |
| Human Immunodeficiency Virus 1 | CAUSES | Human Immunodeficiency Virus Infection |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB01319#mechanism-of-action](https://go.drugbank.com/drugs/DB01319#mechanism-of-action){:target="_blank"}